Lack of females in drug dose trials leads to overmedicated women: Women are more likely than men to suffer adverse side effects of medications because drug dosages have historically been based on clinical trials conducted on men, suggests new research

Lack of females in drug dose trials leads to overmedicated women: Women are more likely than men to suffer adverse side effects of medications because drug dosages have historically been based on clinical trials conducted on men, suggests new research submitted by /u/mubukugrappa
[link] [comments] https://ift.tt/eA8V8J August 14, 2020 at 10:24AM https://ift.tt/1R552o9

Scientists identify hundreds of drug candidates to treat Covid-19

Scientists identify hundreds of drug candidates to treat Covid-19 UC Riverside researchers used a powerful machine learning approach to screen millions of chemicals to find suitable candidates https://ift.tt/eA8V8J

Lack of females in drug dose trials leads to overmedicated women: Women are more likely than men to suffer adverse side effects of medications because drug dosages have historically been based on clinical trials conducted on men, suggests new research

submitted by /u/mubukugrappa
[link] [comments]

TB vaccine shows encouraging results against coronavirus in phase-3 clinical trials

TB vaccine shows encouraging results against coronavirus in phase-3 clinical trials VPM1002, a tuberculosis vaccine, is showing encouraging results against the coronavirus infection in phase-III clinical trials being conducted in Germany. https://ift.tt/eA8V8J

Snoring & Sleep Disturbance - Is It a Threat to our Health?

Snoring & Sleep Disturbance - Is It a Threat to our Health? submitted by /u/TomRipple
[link] [comments]

Racing the clock to stop drug-resistant superbugs

Racing the clock to stop drug-resistant superbugs submitted by /u/zsreport
[link] [comments]

Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vaccine

Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vaccine submitted by /u/milkprogrammer
[link] [comments]